Branch retinal vein occlusion associated with fingolimod treatment for multiple sclerosis

Can J Ophthalmol. 2021 Feb;56(1):e21-e22. doi: 10.1016/j.jcjo.2020.07.015. Epub 2020 Aug 14.

Authors

Jiun L Do¹, Vivek R Patel²

Affiliations

¹ University of California, San Diego, La Jolla, CA.
² University of Southern California, Los Angeles, CA. Electronic address: [email protected].

PMID: 32805204
DOI: 10.1016/j.jcjo.2020.07.015

No abstract available

Publication types

Letter

MeSH terms

Fingolimod Hydrochloride / adverse effects
Fluorescein Angiography
Humans
Multiple Sclerosis* / diagnosis
Multiple Sclerosis* / drug therapy
Retinal Vein Occlusion* / chemically induced
Retinal Vein Occlusion* / diagnosis
Retinal Vein Occlusion* / drug therapy
Retinal Vein*

Substances

Fingolimod Hydrochloride